195 related articles for article (PubMed ID: 23708199)
1. Application of nanofiltration for the removal of carbamazepine, diclofenac and ibuprofen from drinking water sources.
Vergili I
J Environ Manage; 2013 Sep; 127():177-87. PubMed ID: 23708199
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
Strenn B; Clara M; Gans O; Kreuzinger N
Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
[TBL] [Abstract][Full Text] [Related]
3. Redox-sensitivity and mobility of selected pharmaceutical compounds in a low flow column experiment.
Banzhaf S; Nödler K; Licha T; Krein A; Scheytt T
Sci Total Environ; 2012 Nov; 438():113-21. PubMed ID: 22982450
[TBL] [Abstract][Full Text] [Related]
4. Adsorption of selected endocrine disrupting compounds and pharmaceuticals on activated biochars.
Jung C; Park J; Lim KH; Park S; Heo J; Her N; Oh J; Yun S; Yoon Y
J Hazard Mater; 2013 Dec; 263 Pt 2():702-10. PubMed ID: 24231319
[TBL] [Abstract][Full Text] [Related]
5. Mobility of pharmaceuticals carbamazepine, diclofenac, ibuprofen, and propyphenazone in miscible-displacement experiments.
Scheytt TJ; Mersmann P; Heberer T
J Contam Hydrol; 2006 Feb; 83(1-2):53-69. PubMed ID: 16343689
[TBL] [Abstract][Full Text] [Related]
6. Rejection of pharmaceuticals by forward osmosis membranes.
Jin X; Shan J; Wang C; Wei J; Tang CY
J Hazard Mater; 2012 Aug; 227-228():55-61. PubMed ID: 22640821
[TBL] [Abstract][Full Text] [Related]
7. A model assessment of the potential of river water to induce the photochemical attenuation of pharmaceuticals downstream of a wastewater treatment plant (Guadiana River, Badajoz, Spain).
Vione D; Encinas A; Fabbri D; Calza P
Chemosphere; 2018 May; 198():473-481. PubMed ID: 29425948
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of the removal mechanism of carbamazepine and ibuprofen by metal organic framework.
Jun BM; Heo J; Park CM; Yoon Y
Chemosphere; 2019 Nov; 235():527-537. PubMed ID: 31276866
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
10. Determination of sorption coefficients of pharmaceutically active substances carbamazepine, diclofenac, and ibuprofen, in sandy sediments.
Scheytt T; Mersmann P; Lindstädt R; Heberer T
Chemosphere; 2005 Jul; 60(2):245-53. PubMed ID: 15914244
[TBL] [Abstract][Full Text] [Related]
11. Biodegradation of ibuprofen, diclofenac and carbamazepine in nitrifying activated sludge under 12 °C temperature conditions.
Kruglova A; Ahlgren P; Korhonen N; Rantanen P; Mikola A; Vahala R
Sci Total Environ; 2014 Nov; 499():394-401. PubMed ID: 25215408
[TBL] [Abstract][Full Text] [Related]
12. Achieving low concentrations of chromium in drinking water by nanofiltration: membrane performance and selection.
Giagnorio M; Ruffino B; Grinic D; Steffenino S; Meucci L; Zanetti MC; Tiraferri A
Environ Sci Pollut Res Int; 2018 Sep; 25(25):25294-25305. PubMed ID: 29946838
[TBL] [Abstract][Full Text] [Related]
13. The removal of endocrine disrupting compounds, pharmaceutically activated compounds and cyanobacterial toxins during drinking water preparation using activated carbon--a review.
Delgado LF; Charles P; Glucina K; Morlay C
Sci Total Environ; 2012 Oct; 435-436():509-25. PubMed ID: 22885596
[TBL] [Abstract][Full Text] [Related]
14. Role of biodegradation in the removal of pharmaceutically active compounds with different bulk organic matter characteristics through managed aquifer recharge: batch and column studies.
Maeng SK; Sharma SK; Abel CD; Magic-Knezev A; Amy GL
Water Res; 2011 Oct; 45(16):4722-36. PubMed ID: 21802106
[TBL] [Abstract][Full Text] [Related]
15. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment.
Radjenović J; Petrović M; Ventura F; Barceló D
Water Res; 2008 Aug; 42(14):3601-10. PubMed ID: 18656225
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health.
Simazaki D; Kubota R; Suzuki T; Akiba M; Nishimura T; Kunikane S
Water Res; 2015 Jun; 76():187-200. PubMed ID: 25835589
[TBL] [Abstract][Full Text] [Related]
17. [Researches on factors affecting the removal of carbamazepine by nanofiltration membranes].
Huang Y; Zhang H; Dong BZ
Huan Jing Ke Xue; 2011 Mar; 32(3):705-10. PubMed ID: 21634167
[TBL] [Abstract][Full Text] [Related]
18. Batch versus continuous feeding strategies for pharmaceutical removal by subsurface flow constructed wetland.
Zhang DQ; Gersberg RM; Zhu J; Hua T; Jinadasa KB; Tan SK
Environ Pollut; 2012 Aug; 167():124-31. PubMed ID: 22564400
[TBL] [Abstract][Full Text] [Related]
19. Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment.
Liu J; Dan X; Lu G; Shen J; Wu D; Yan Z
Ecotoxicol Environ Saf; 2018 Jun; 154():214-220. PubMed ID: 29476970
[TBL] [Abstract][Full Text] [Related]
20. Nanofiltration as tertiary treatment method for removing trace pharmaceutically active compounds in wastewater from wastewater treatment plants.
Garcia-Ivars J; Martella L; Massella M; Carbonell-Alcaina C; Alcaina-Miranda MI; Iborra-Clar MI
Water Res; 2017 Nov; 125():360-373. PubMed ID: 28881212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
